SCHEMBL14034409

SCHEMBL14034409

Cc1cc(-c2ccc(F)cc2)nc2ccncc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 1/20 0.48
ALDH1A1 P00352 4/20 0.45
GAA P10253 1/20 0.45
DHODH Q02127 3/20 0.44
PKM P14618 1/20 0.43
TOP1 P11387 2/20 0.43
CYP19A1 P11511 1/20 0.43
CSNK2A2 P19784 1/20 0.42
CSNK2B P67870 1/20 0.42
MEN1 O00255 2/20 0.41
MAPT P10636 2/20 0.41
KMT2A Q03164 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
KDM4E B2RXH2 2/20 0.40
LMNA P02545 2/20 0.40
RECQL P46063 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
MAPK1 P28482 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
GRM2 Q14416 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14034383 0.88 MAPT (0.49) ALDH1A1GAADHODHMEN1MAPT
SCHEMBL14034296 0.86 ALDH1A1 (0.54) ALDH1A1GAADHODHPKMCYP19A1
SCHEMBL14034221 0.84 CSNK2A2 (0.46) ALDH1A1GAADHODHCSNK2A2CSNK2B
SCHEMBL4247635 0.82 ACHE (0.49) MAPK14ALDH1A1GAADHODHPKM
SCHEMBL4857363 0.82 ALDH1A1 (0.48) ALDH1A1GAADHODHPKMTOP1
SCHEMBL15919273 0.81 ESR1 (0.47) MAPK14ALDH1A1GAADHODHPKM
SCHEMBL15919444 0.81 ALDH1A1 (0.47) ALDH1A1GAADHODHPKMTOP1
SCHEMBL12525154 0.80 ALDH1A1 (0.61) ALDH1A1GAADHODHTOP1CYP19A1
SCHEMBL4252230 0.78 ALDH1A1 (0.69) ALDH1A1GAADHODHCSNK2A2CSNK2B
SCHEMBL14034400 0.78 MEN1 (0.49) MAPK14ALDH1A1DHODHMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7446112-B2 Modulators of muscarinic receptors VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-11-04 US disclosed